Microneedle Patch Delivering Chemotherapy Shows Promise Against Common Skin Cancer in Phase 2 Trial
Newswise — Philadelphia, PA – March 5, 2026 – An experimental microneedle patch designed to deliver chemotherapy directly into skin tumors showed encouraging results in a Phase 2 clinical trial for basal cell carcinoma, the most common type of skin cancer. Biotech company Medicus Pharma reported…